Abionyx Pharma SA
PAR:ABNX
Abionyx Pharma SA
PAR:ABNX
Price:
2.7
EUR
-2.7%
Market Cap:
€114.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Abionyx Pharma SA
PAR:ABNX
|
FR |
|
H
|
Hartford Financial Services Group Inc
F:HFF
|
US |
|
C
|
Construcciones Y Auxiliar De Ferrocarriles SA
MAD:CAF
|
ES |
|
A
|
Alphabet Inc
F:ABEA
|
US |
|
Ted Baker PLC
LSE:TED
|
UK |
|
Derichebourg SA
PAR:DBG
|
FR |
|
Bourse Direct SA
F:BD6
|
FR |
|
Essity AB (publ)
STO:ESSITY A
|
SE |
|
Dynex Capital Inc
NYSE:DX
|
US |
Wall St Price Targets
ABNX Price Targets Summary
Abionyx Pharma SA
Abionyx Pharma SA
Wall Street analysts forecast ABNX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for ABNX is 10.55 EUR with a low forecast of 9.95 EUR and a high forecast of 11.38 EUR.
Lowest Forecast
Price Target
9.95
EUR
268% Upside
Average Forecast
Price Target
10.55
EUR
291% Upside
Highest Forecast
Price Target
11.38
EUR
321% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABNX's stock price target?
Price Target
10.55
EUR
10.55
EUR
According to Wall Street analysts, the average 1-year price target for ABNX is 10.55 EUR with a low forecast of 9.95 EUR and a high forecast of 11.38 EUR.
What is the Revenue forecast for Abionyx Pharma SA?
Projected CAGR
112%
112%
The compound annual growth rate for Revenue over the next 3 years is 112%.
